Filing Details

Accession Number:
0001225208-13-005021
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-02-21 18:06:45
Reporting Period:
2013-02-20
Filing Date:
2013-02-21
Accepted Time:
2013-02-21 18:06:45
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
14272 Bristol Myers Squibb Co BMY Pharmaceutical Preparations (2834) 220790350
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1198959 M James Cornelius Bristol-Myers Squibb Company
345 Park Avenue
New York NY 10154
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, $0.10 Par Value Disposition 2013-02-20 10,000 $36.87 1,091,218 No 4 S Direct
Common Stock, $0.10 Par Value Disposition 2013-02-21 10,000 $36.67 1,081,218 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 15, 2012.
  2. The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $36.70 to $36.98, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
  3. The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $36.59 to $36.76, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.